CyFlow™ CD3 act. PE

CyFlow™ CD3 act. PE
Laser: Blue, Green, Yellow
Target Species: Human, Mouse
Antigen: CD3 (activation epitope)
Field of Interest: Immunophenotyping
Clone: APA1/1
Regulatory Status: RUO
Application: Flow cytometry
Format/Fluorochrome: PE
Species of Origin: Mouse
Clonality: monoclonal
Emission Maximum: 576 nm
Excitation Maximum: 496 nm, 565 nm
Isotype: IgG1
Product number: CM152332

For Research Use Only

HLDA Workshop HLDA III—WS Code T 126 Concentration 0.1 mg/mL Quantity 0.1 mg... more
CyFlow™ CD3 act. PE
HLDA WorkshopHLDA III—WS Code T 126
Concentration0.1 mg/mL
Quantity0.1 mg
Volume1.0 mL
ImmunogenPurified human CD3 proteins isolated from thymus
Background InformationCD3 complex is crucial in transducing antigen-recognition signals into the cytoplasm of T cells and in regulating the cell surface expression of the TCR complex. T cell activation through the antigen receptor (TCR) involves the cytoplasmic tails of the CD3 subunits CD3γ, CD3 δ, CD3ε and CD3ζ. These CD3 subunits are structurally related members of the immunoglobulins superfamily encoded by closely linked genes on human chromosome 11. The CD3 components have long cytoplasmic tails that associate with cytoplasmic signal transduction molecules. This association is mediated at least in part by a double tyrosine-based motif present in a single copy in the CD3 subunits. CD3 may play a role in TCR-induced growth arrest, cell survival and proliferation.
UsageThe reagent is designed for Flow Cytometry analysis. Suggested working usage is 5·µg/ml. Indicated dilution is recommended starting point for use of this product, but working concentrations should be validated by the investigator.
Storage BufferThe reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.

Specific References

| Alarcón B, Ley SC, Sánchez-Madrid F, Blumberg RS, Ju ST, Fresno M, Terhorst C: The CD3‑gamma and CD3‑delta subunits of the T cell antigen receptor can be expressed within distinct functional TCR/CD3 complexes. EMBO·J. 1991·Apr; 10(4):903‑12. <·PMID:·1826255·> | Delgado P, Fernández E, Dave V, Kappes D, Alarcón B: CD3delta couples T‑cell receptor signalling to ERK activation and thymocyte positive selection. Nature. 2000·Jul·27; 406(6794):426‑30. <·PMID:·10935641·> | Torres PS, Alcover A, Zapata DA, Arnaud J, Pacheco A, Martín-Fernández JM, Villasevil EM, Sanal O, Regueiro JR: TCR dynamics in human mature T lymphocytes lacking CD3 gamma. J·Immunol. 2003·Jun·15; 170(12):5947‑55. <·PMID:·12794121·> | Gil D, Schrum AG, Alarcón B, Palmer E: T cell receptor engagement by peptide‑MHC ligands induces a conformational change in the CD3 complex of thymocytes. J·Exp·Med. 2005·Feb·21; 201(4):517‑22. <·PMID:·15728235·> | Risueño RM, Gil D, Fernández E, Sánchez-Madrid F, Alarcón B: Ligand‑induced conformational change in the T‑cell receptor associated with productive immune synapses. Blood. 2005·Jul·15; 106(2):601‑8. <·PMID:·15790785·> | Rieux-Laucat F, Hivroz C, Lim A, Mateo V, Pellier I, Selz F, Fischer A, Le Deist F: Inherited and somatic CD3zeta mutations in a patient with T‑cell deficiency. N·Engl·J·Med. 2006·May·4; 354(18):1913‑21. <·PMID:·16672702·> | Risueño RM, van Santen HM, Alarcón B: A conformational change senses the strength of T cell receptor‑ligand interaction during thymic selection. Proc·Natl·Acad·Sci·USA. 2006·Jun·20; 103(25):9625‑30. <·PMID:·16766661·> | Wong AP, Dutly AE, Sacher A, Lee H, Hwang DM, Liu M, Keshavjee S, Hu J, Waddell TK: Targeted cell replacement with bone marrow cells for airway epithelial regeneration. Am·J·Physiol·Lung·Cell·Mol·Physiol. 2007·Sep; 293(3):L740‑52. <·PMID:·17616650·> | Tailor P, Tsai S, Shameli A, Serra P, Wang J, Robbins S, Nagata M, Szymczak-Workman AL, Vignali DA, Santamaria P: The proline‑rich sequence of CD3epsilon as an amplifier of low‑avidity TCR signaling. J·Immunol. 2008·Jul·1; 181(1):243‑55. <·PMID:·18566390·>

Article successfully added.